Literature DB >> 8970776

Chronic paronychia and onycholysis: a thirteen-year experience.

C R Daniel1, M P Daniel, C M Daniel, S Sullivan, G Ellis.   

Abstract

We report here on two retrospective studies conducted between 1982 and 1995 in 137 patients with clinical evidence of chronic paronychia or onycholysis. The purpose of the studies was to determine what factors played a role in these nail disorders. The culture results indicated that yeast commonly grew from the cultured material. Significant contact irritant exposure was frequently found. These findings and our experience suggest that the resolution of chronic paronychia and onycholysis depends on avoiding exposure to contact irritants and on appropriate treatment of any underlying fungal infection. To accomplish this latter goal, it is important to select a broad-spectrum antifungal agent that is effective against yeasts as well as other fungal pathogens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970776

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  8 in total

1.  Experience with thymol in chloroform solution for the treatment of paronychia.

Authors:  Carolina Olaizola; Celina Pérez; Sofía Mata-Essayag; Claudia Hartung; Maria Teresa Collela; Sylvia Magaldi; Arantza Roselló
Journal:  Mycopathologia       Date:  2005-02       Impact factor: 2.574

2.  Occurrence of Candida strains in cases of paronychia.

Authors:  E Dorko; J Jautová; E Pilipcinec; L Tkáciková
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

3.  An Update on the Disappearing Nail Bed.

Authors:  Ralph Daniel; Babaev Meir; Shemer Avner
Journal:  Skin Appendage Disord       Date:  2017-01-06

4.  A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.

Authors:  Kara D Capriotti; Milan Anadkat; Jennifer Choi; Benjamin Kaffenberger; Beth McLellan; Samuel Barone; Oluwaseun Kukoyi; Shari Goldfarb; Mario Lacouture
Journal:  Invest New Drugs       Date:  2019-06-26       Impact factor: 3.850

5.  1064 Nd:YAG laser for the treatment of chronic paronychia: a pilot study.

Authors:  M H M El-Komy; N Samir
Journal:  Lasers Med Sci       Date:  2013-12-11       Impact factor: 3.161

Review 6.  Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

Authors:  Mario E Lacouture; Milan J Anadkat; René-Jean Bensadoun; Jane Bryce; Alexandre Chan; Joel B Epstein; Beth Eaby-Sandy; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2011-06-01       Impact factor: 3.603

Review 7.  Infections of the hand: an overview.

Authors:  Dimitrios A Flevas; Sophia Syngouna; Emmanouel Fandridis; Sotirios Tsiodras; Andreas F Mavrogenis
Journal:  EFORT Open Rev       Date:  2019-05-10

8.  Natural coniferous resin lacquer in treatment of toenail onychomycosis: an observational study.

Authors:  Pentti Sipponen; Arno Sipponen; Jouni Lohi; Marjo Soini; Riikka Tapanainen; Janne J Jokinen
Journal:  Mycoses       Date:  2012-11-06       Impact factor: 4.377

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.